Clinical Trial: Study of VELCADE for Relapsed or Refractory T-cell Prolymphocytic Leukemia
Sponsor and CollaboratorsStanford University
Millennium Pharmaceuticals, Inc.
ContactContact: Richa Rajwanshi
(650) 736-4031
richar@stanford.edu
Principal InvestigatorBruno Carneiro de Medeiros Stanford University
ClinicalTrials.gov IdentifierNCT01162031